Please Wait
{{vm.model.title}}
{{vm.model.overview}}
Recommended Products for You
ApoE Genetic Test for Alzheimer’s and Cardiac Risk Cheek Swab
Item # LC100059
Evaluate ApoE gene to identify cardiac and Alzheimer's risk
Click to Zoom
Click to Zoom
ApoE Genetic Test for Alzheimer’s and Cardiac Risk Cheek Swab
Item # LC100059
Evaluate ApoE gene to identify cardiac and Alzheimer's risk
Variants in the ApoE gene are associated with the risk of Alzheimer’s disease and cardiovascular disease. This cheek swab test determines which of the E2, E3, or E4 variants of ApoE you have, thereby assessing your level of genetic risk.
Apolipoprotein E (ApoE) is an important regulator of cholesterol and triglyceride levels in your blood and supports lipid transport and injury repair in your brain.1
Alzheimer's disease (AD) is a progressive disease associated with the aggregation of proteins called amyloidß (Aß) and tau, which deposit in AD brains as plaques and tangles. These plaques and tangles injure synapses in your brain and ultimately cause neurodegeneration and dementia.2,3
AD usually occurs later in life (>65 years) and is referred to as late-onset AD (LOAD). Although multiple genetic and environmental risk factors are involved in LOAD, impairment in Aß clearance by ApoE is a major contributor to development of the disease.4
There are three different forms of the ApoE gene known as E2, E3 and E4 alleles. Genetically, E4 is the strongest risk factor for developing LOAD.5-7 According to the National Institute of Health, inheriting a single copy of ApoE4 from a parent increases the risk of Alzheimer's disease by about three-fold. Inheriting two copies, one from each parent, increases the risk by about 12-fold.8 In fact almost 40% of AD patients have inherited an E4 allele.9
In the cardiovascular system ApoE is involved in the transportation of fat molecules out of circulation and into your cells.10 Each of the allele variations, E2, E3 and E4 mediate cholesterol metabolism in a different manner. E4 is associated with increased levels of cholesterol and triglycerides, which leads to atherosclerosis, heart disease and stroke.11
This panel identifies your risk category so you can take important steps to change your lifestyle before symptoms become evident!
Allele Type |
Cardiac Risk |
Alzheimer's Risk |
E2 |
Associated with a decreased risk for cardiovascular disease except for individuals with hyperlipoproteinemia. |
Studies indicate that people with this variant are at a reduced risk for developing Late Onset Alzheimer’s Disease.12 |
E3 |
Considered the non-risk group for cardiovascular disease.1,13,14 |
Results in normal expression of ApoE and believed to play a neutral role in the disease, neither increasing or decreasing risk.12 |
E4 |
Associated with the highest risk for cardiovascular disease due to decreased HDL levels, increased triglycerides1 and cholesterol levels (both total and LDL).1 It is also associated with increased risk of heart attack7 and stroke11. |
E4/E4 carries the highest risk and may increase risk up to 12 fold with an earlier age of disease onset.8 The ApoE4 variant is implicated in 40% of Alzheimer's cases.8 |
It is important to understand that although carrying the ApoE E4 allele increases your likelihood of developing disease, it does not mean that you will. Genetic testing is about probabilities, not guarantees - and should always be interpreted in the light of other considerations such as age, family history, environmental factors, ethnicity, and other coexisting medical conditions.
Instructions
The following documents provide a full set of instructions for completing the test:
Note
Results take 2-3 weeks from when specimen is received. This test is not available in Pennsylvania. The results for this test can only be received via mail, e-mail, or fax. Since gene variants do not change over time, each person needs to be tested only once in their lifetime.
References
- Mahley RW et al. Apolipoprotein E: Far More Than a Lipid Transport Protein. Annu Rev Genomics Hum Genet. 2000; 1:507-537.
- Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353–356 (2002).
- Blennow, K., de Leon, M. J. & Zetterberg, H. Alzheimer’s disease. Lancet 368, 387–403 (2006).
- Mawuenyega, K. G. et al. Decreased clearance of CNS ß-amyloid in Alzheimer’s disease. Science 330, 1774 (2010).
- Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921–923 (1993).
- Bu, G. Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy. Nat. Rev. Neurosci. 10, 333–344 (2009).
- Huang, Y. & Mucke, L. Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204–1222 (2012).
- https://www.nih.gov/news-events/news-releases/nih-funded-research-provides-new-clues-how-apoe4-affects-alzheimers-risk
- Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 278, 1349–1356 (1997).
- Hyperlipoporteinemia Type III. https://rarediseases.org/rare-diseases/hyperlipoproteinemia-type-iii/
- https://www.alz.org/alzheimers-dementia/research_progress/earlier-diagnosis#apoe
- https://www.nia.nih.gov/health/alzheimers-disease-genetics-fact-sheet
- Eichner JE et al. Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review. Am J Epidemiol. 2002; 155(6):487-495.
- Villeneuve S et al. The potential applications of Apolipoprotein E in personalized medicine. Front Aging Neurosci. 2014; 6:154.
The laboratory services are for informational purposes only. It is not the intention of National Diagnostics, Inc and Life Extension to provide specific medical advice but rather to provide users with information to better understand their health. Specific medical advice including diagnosis and treatment will not be provided. Always seek the advice of a trained health professional for medical advice, diagnosis or treatment.
Both the physician and the testing laboratory are independent contractors with whom National Diagnostics, Inc makes arrangements for your blood tests. Neither National Diagnostics, Inc or Life Extension will be liable for any acts or omissions of the physician, the testing laboratory, or their agents or employees.
A clinician's order is required for many tests. Where applicable, an independent clinician will review your test request and determine whether to authorize the test, if appropriate. For additional information, see PWNHealth Terms of Service.
Life Extension - Why We Do It?
The Best Supplements Science Can Offer
When putting something in your body, you should be confident that you’re getting the nutritional benefits your body deserves. We've been delivering high-quality, science-backed supplements for more than 40 years.
What Matters to You, Matters to Us
We're committed to empowering you to live a healthier life. Whether it’s finding sustainable partners for our ingredients or funding the latest anti-aging research, we're all about your health & wellness.
Highly Recommended
98% of our customers recommend us to family and friends. We're very proud of that because our loved ones matter to us—and we're willing to bet you feel the same way.
Product Transparency
40 years of research dedicated to bringing you premium, scientifically-validated formulations.
Product reviews are provided for informational purposes only and reflect solely the views and opinions expressed by the contributors and not those of Life Extension. We do not verify or endorse any claims made in these reviews. Full product reviews disclaimer
Related Lab Test
Omega-3 Index Complete Finger Stick Test
Are you getting enough Omega-3 and other fatty acids?
$99.00
